Holdings
Armistice Capital, LLC
As of Jun 30, 2026, Armistice Capital, LLC reported 289 positions worth US$3.47B. Largest: Madrigal Pharmaceuticals, Inc., Supernus Pharmaceuticals, Inc. and Cytokinetics, Incorporated. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Madrigal Pharmaceuticals, Inc. | 288K | US$155M | +23,417 | Jun 30, 2026 |
| Supernus Pharmaceuticals, Inc. | 2.65M | US$123M | +751K | Jun 30, 2026 |
| Cytokinetics, Incorporated | 1.2M | US$102M | +437K | Jun 30, 2026 |
| Incyte Corporation | 900K | US$102M | +243K | Jun 30, 2026 |
| Neurocrine Biosciences, Inc. | 536K | US$90.3M | −188K | Jun 30, 2026 |
| Travere Therapeutics, Inc. | 1.57M | US$89.3M | −3.32M | Jun 30, 2026 |
| Agios Pharmaceuticals, Inc. | 2.4M | US$89.1M | −316K | Jun 30, 2026 |
| Ptc Therapeutics, Inc. | 1.07M | US$87.4M | −1M | Jun 30, 2026 |
| Unitedhealth Group Incorporated | 183K | US$76.1M | +35,000 | Jun 30, 2026 |
| Freshpet, Inc. | 1.26M | US$74.5M | +167K | Jun 30, 2026 |